您的位置: 首页 > 农业专利 > 详情页

6-QUINOXALINAMINE DERIVATIVES AS INHIBITORS OF THE NEURAMINIDASE OF THE INFLUENZA A H1N1 VIRUS.
专利权人:
UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
发明人:
MARCO IGOR VALENCIA SÁNCHEZ,ARMANDO GÓMEZ PUYOU,ALFREDO TORRES LARIOS
申请号:
MX2012014556
公开号:
MX337980B
申请日:
2012.12.13
申请国别(地区):
MX
年份:
2016
代理人:
摘要:
The present invention is intended to find novel Hemagglutinin (HA) and neuraminidase (NA) inhibitors of influenza A H1N1 virus, which is based on the search of fragments. The invention refers to compounds pertaining to the biotechnological field which have antiviral activity, particularly against Influenza A H1N1. The compounds are based on principles for designing drugs by fragments search the scrutiny of the Maybridge Library Ro3 of 1000 chemical compounds was performed, evaluating the effect of the compounds over the HA and NA of the human influenza virus. The recombinant neuraminidase was incubated with the compounds, stimulating the inhibition of the enzyme activity, detecting the fluorescent product of the reaction, where the scrutiny of the HA, was performed for determining the inhibition of the Hemagglutinin activity of the influenza virus upon being incubated with the compounds. The influenza A H1N1 virus Mexico/2009 used in the essays was produced in cells MDCK growing over microcarriers suspended in a serum-free medium. Five HA inhibiting compounds were found as well as thirteen NA inhibiting compounds. The 1-azepanyl (3 piperidinyl) methanone (AzPM) compound and the 6-aminoquinoxaline (AQA) compound with activity over the NA, were consciously studied. The identity and purity of the Az PM were confirmed by the RMN of 13C. The AzPM was confirmed as inhibitor of recombinant NA. In addition, it was found that the NA inhibition performed by the AzPM is reduced in the presence of calcium, since it is intended to maintain the thermal stability and the quaternary structure of the NA. The AQA compound at 95% was confirmed as a NA inhibitor in the context of the influenza A H1N1 virus.La presente invención tiene como objetivo principal encontrar nuevos inhibidores dirigidos contra la hemaglutinina (HA) y la neuraminidasa (NA) del virus de la influenza A (H1N1), basada en la búsqueda de fragmentos. La presente invención se refiere a compuestos en el campo biotecnol
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充